Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-18

FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals' supplemental application for olopatadine hydrochloride, updating an already-approved product. The approval typically cover…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

SUPPL AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)